# Temozolomide and Radiation Therapy in Treating Patients With Gliomas

> **NCT00114140** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 136 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** Temozolomide
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT00114140
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2013-02
- **Final completion:** 2022-05-20
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2024-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114140, "Temozolomide and Radiation Therapy in Treating Patients With Gliomas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00114140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*